156 related articles for article (PubMed ID: 25245440)
1. Appropriateness of imaging for lung cancer staging in a national cohort.
Backhus LM; Farjah F; Varghese TK; Cheng AM; Zhou XH; Wood DE; Kessler L; Zeliadt SB
J Clin Oncol; 2014 Oct; 32(30):3428-35. PubMed ID: 25245440
[TBL] [Abstract][Full Text] [Related]
2. Association of Receipt of Positron Emission Tomography-Computed Tomography With Non-Small Cell Lung Cancer Mortality in the Veterans Affairs Health Care System.
Vella M; Meyer CS; Zhang N; Cohen BE; Whooley MA; Wang S; Hope MD
JAMA Netw Open; 2019 Nov; 2(11):e1915828. PubMed ID: 31747036
[TBL] [Abstract][Full Text] [Related]
3. Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?
Hillner BE; Tosteson AN; Song Y; Tosteson TD; Onega T; Goodman DC; Siegel BA
J Am Coll Radiol; 2012 Jan; 9(1):33-41. PubMed ID: 22221634
[TBL] [Abstract][Full Text] [Related]
4. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
Sehdev A; Sherer EA; Hui SL; Wu J; Haggstrom DA
Cancer; 2017 Jun; 123(12):2338-2351. PubMed ID: 28211937
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Use of (18)F-Fluorodeoxyglucose PET Imaging in Surveillance of Non-Small-Cell Lung and Colorectal Cancer.
Veenstra CM; Vachani A; Ciunci CA; Zafar HM; Epstein AJ; Paulson EC
J Am Coll Radiol; 2016 May; 13(5):491-6. PubMed ID: 26774883
[TBL] [Abstract][Full Text] [Related]
6. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
Balekian AA; Fisher JM; Gould MK
Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
[TBL] [Abstract][Full Text] [Related]
7. Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer.
Vest MT; Tanoue L; Soulos PR; Kim AW; Detterbeck F; Morgensztern D; Gross CP
J Thorac Oncol; 2012 Jan; 7(1):188-95. PubMed ID: 22134069
[TBL] [Abstract][Full Text] [Related]
8. Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer.
Lupichuk S; Tilley D; Surgeoner B; King K; Joy AA
Can J Surg; 2020 Feb; 63(2):E100-E109. PubMed ID: 32109016
[TBL] [Abstract][Full Text] [Related]
9. Predictors of imaging surveillance for surgically treated early-stage lung cancer.
Backhus LM; Farjah F; Zeliadt SB; Varghese TK; Cheng A; Kessler L; Au DH; Flum DR
Ann Thorac Surg; 2014 Dec; 98(6):1944-51; discussion 1951-2. PubMed ID: 25282167
[TBL] [Abstract][Full Text] [Related]
10. Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.
Henry NL; Braun TM; Breslin TM; Gorski DH; Silver SM; Griggs JJ
Cancer; 2017 Aug; 123(15):2975-2983. PubMed ID: 28301680
[TBL] [Abstract][Full Text] [Related]
11. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.
Wang S; Wong ML; Hamilton N; Davoren JB; Jahan TM; Walter LC
J Clin Oncol; 2012 May; 30(13):1447-55. PubMed ID: 22454424
[TBL] [Abstract][Full Text] [Related]
12. Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry.
Hong JC; Boyer MJ; Spiegel DY; Williams CD; Tong BC; Shofer SL; Moravan MJ; Kelley MJ; Salama JK
J Natl Compr Canc Netw; 2019 Feb; 17(2):127-139. PubMed ID: 30787126
[No Abstract] [Full Text] [Related]
13. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
14. Use of Positron Emission Tomography to Detect Recurrence and Associations With Survival in Patients With Lung and Esophageal Cancers.
Healy MA; Yin H; Reddy RM; Wong SL
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26903519
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of [18F] FDG PET-CT compared to bone scintigraphy for the detection of bone metastases in lung cancer patients.
Rodrigues M; Stark H; Rendl G; Rettenbacher L; Datz L; Studnicka M; Pirich C
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):62-8. PubMed ID: 26844431
[TBL] [Abstract][Full Text] [Related]
16.
Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
[TBL] [Abstract][Full Text] [Related]
17. The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer.
Min JW; Um SW; Yim JJ; Yoo CG; Han SK; Shim YS; Kim YW
J Korean Med Sci; 2009 Apr; 24(2):275-80. PubMed ID: 19399270
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer.
Grogan EL; Deppen SA; Ballman KV; Andrade GM; Verdial FC; Aldrich MC; Chen CL; Decker PA; Harpole DH; Cerfolio RJ; Keenan RJ; Jones DR; D'Amico TA; Shrager JB; Meyers BF; Putnam JB
Ann Thorac Surg; 2014 Apr; 97(4):1142-8. PubMed ID: 24576597
[TBL] [Abstract][Full Text] [Related]
19. Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data.
Gregory DL; Hicks RJ; Hogg A; Binns DS; Shum PL; Milner A; Link E; Ball DL; Mac Manus MP
J Nucl Med; 2012 Jul; 53(7):1007-15. PubMed ID: 22677701
[TBL] [Abstract][Full Text] [Related]
20. Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.
Gould MK; Schultz EM; Wagner TH; Xu X; Ghaus SJ; Wallace RB; Provenzale D; Au DH
J Thorac Oncol; 2011 May; 6(5):875-83. PubMed ID: 21572580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
